Related Experiment Video

Updated: Aug 15, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management

D Hacking1, R Smyth, N Shaw

  • 1Neonatal Unit, Royal Children's Hospital, Flemington Road, Melbourne, Australia. hackandmack@lwcdial.net

Archives of Disease in Childhood
|July 25, 2000
PubMed

Insights

Pediatric pulmonary interstitial fibrosis, a rare condition, showed a good prognosis in 11 children treated conservatively. This contrasts with previously reported high mortality rates in similar pediatric lung disease cases.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Interstitial Lung Disease

Background:

  • Pulmonary interstitial fibrosis in children is a rare condition.
  • Its etiology is often unknown.
  • It is typically associated with a poor prognosis.

Purpose of the Study:

  • To describe a case series of 11 children with pulmonary interstitial fibrosis.
  • To evaluate the prognosis and management of these pediatric patients.
  • To compare findings with existing literature on pediatric lung disease.

Main Methods:

  • A 10-year case series of 11 children diagnosed with pulmonary interstitial fibrosis.
  • Diagnosis confirmed via chest computed tomography and percutaneous lung biopsy.
  • Conservative management including oral prednisolone, hydroxychloroquine, and home oxygen therapy.

Main Results:

  • All 11 patients survived at a median follow-up age of 6 years.
  • Symptoms were often congenital or appeared within the first 3 months of life.
  • While some patients experienced dyspnea on exertion, two were symptom-free at follow-up.

Conclusions:

  • The observed good prognosis in this cohort differs significantly from previous reports of high mortality.
  • Conservative management strategies may lead to better outcomes in pediatric pulmonary interstitial fibrosis.
  • Further research is needed to understand the variable prognosis in this pediatric lung disease.
Abstract

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...